AEON Biopharma, Inc. Class A Common Stock

Share · US00791X1000 · AEON (XNYS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of AEON Biopharma, Inc. Class A Common Stock

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

28.04.2026 23:14

Current Prices from AEON Biopharma, Inc. Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NYSE	AEON	USD	28.04.2026 23:14	1,03 USD	-0,01 USD -1,44 %
AMEX	AEON	USD	28.04.2026 19:54	0,99 USD	-0,05 USD -5,25 %
IEX	AEON	USD	22.04.2026 19:59	1,08 USD	-

Share Float & Liquidity

Free Float 69,08 %

Shares Float 8,17 M

Shares Outstanding 11,83 M

Company Profile for AEON Biopharma, Inc. Class A Common Stock Share

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.